Caplin Point Laboratories gets FDA approval for Prochlorperazine Edisylate Injection
Caplin Point Laboratories said that its subsidiary Caplin Steriles has secured final approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for Prochlorperazine Edisylate Injection USP, 10 mg/2 mL (5 mg/mL) Vials presentations. Prochlorperazine Edisylate Injection is a generic therapeutic equivalent version of (RLD), COMPAZINE Injection, manufactured by […]